High Throughput Genetic Analysis of Congenital Myasthenic Syndromes Using Resequencing Microarrays
Open Access
- 19 September 2007
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 2 (9) , e918
Abstract
The use of resequencing microarrays for screening multiple, candidate disease loci is a promising alternative to conventional capillary sequencing. We describe the performance of a custom resequencing microarray for mutational analysis of Congenital Myasthenic Syndromes (CMSs), a group of disorders in which the normal process of neuromuscular transmission is impaired. Our microarray was designed to assay the exons and flanking intronic regions of 8 genes linked to CMSs. A total of 31 microarrays were hybridized with genomic DNA from either individuals with known CMS mutations or from healthy controls. We estimated an overall microarray call rate of 93.61%, and we found the percentage agreement between the microarray and capillary sequencing techniques to be 99.95%. In addition, our microarray exhibited 100% specificity and 99.99% reproducibility. Finally, the microarray detected 22 out of the 23 known missense mutations, but it failed to detect all 7 known insertion and deletion (indels) mutations, indicating an overall sensitivity of 73.33% and a sensitivity with respect to missense mutations of 95.65%. Overall, our microarray prototype exhibited strong performance and proved highly efficient for screening genes associated with CMSs. Until indels can be efficiently assayed with this technology, however, we recommend using resequencing microarrays for screening CMS mutations after common indels have been first assayed by capillary sequencing.Keywords
This publication has 21 references indexed in Scilit:
- Dok-7 Mutations Underlie a Neuromuscular Junction SynaptopathyScience, 2006
- A transforming MET mutation discovered in non-small cell lung cancer using microarray-based resequencingCancer Letters, 2006
- Sequencing Arrays for Screening Multiple Genes Associated with Early-Onset Human Retinal Degenerations on a High-Throughput PlatformInvestigative Ophthalmology & Visual Science, 2005
- Current understanding of congenital myasthenic syndromesCurrent Opinion in Pharmacology, 2005
- Screening candidate genes for mutations in patients with hypogonadotropic hypogonadism using custom genome resequencing microarraysAmerican Journal of Obstetrics and Gynecology, 2005
- A newly identified chromosomal microdeletion of the rapsyn gene causes a congenital myasthenic syndromeNeuromuscular Disorders, 2004
- Congenital myasthenic syndromes: Progress over the past decadeMuscle & Nerve, 2002
- Rapsyn Mutations in Humans Cause Endplate Acetylcholine-Receptor Deficiency and Myasthenic SyndromeThe American Journal of Human Genetics, 2002
- A map of human genome sequence variation containing 1.42 million single nucleotide polymorphismsNature, 2001
- Resequencing and mutational analysis using oligonucleotide microarraysNature Genetics, 1999